Literature DB >> 22780692

Cardiovascular disease in chronic kidney disease: untying the Gordian knot.

R Hajhosseiny1, K Khavandi, D J Goldsmith.   

Abstract

Chronic kidney disease (CKD) affects around 10-13% of the general population, with only a small proportion in end stage renal disease (ESRD), either on dialysis or awaiting renal transplantation. It is well documented that CKD patients have an extremely high risk of developing cardiovascular disease (CVD) compared with the general population, so much so that in the early stages of CKD patients are more likely to develop CVD than they are to progress to ESRD. Various pathophysiological pathways and explanations have been advanced and suggested to account for this, including endothelial dysfunction, dyslipidaemia, inflammation, left ventricular hypertrophy and cardiac autonomic dysfunction. In this review, we try to understand and further explore the link between CKD and CVD, as well as offering interventional advice where available, while exposing the current lack of RCT-based research and trial evidence in this area. We also suggest pragmatic Interim measures we could take while we wait for definitive RCTs.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22780692     DOI: 10.1111/j.1742-1241.2012.02954.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  17 in total

Review 1.  Remote ischaemic conditioning-therapeutic opportunities in renal medicine.

Authors:  Lisa E Crowley; Christopher W McIntyre
Journal:  Nat Rev Nephrol       Date:  2013-11-05       Impact factor: 28.314

Review 2.  Vitamin K status in chronic kidney disease: a report of a study and a mini-review.

Authors:  Kieran Voong; Dominic Harrington; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2013-01-08       Impact factor: 2.370

3.  Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.

Authors:  Ritwik Dey; Medha Rajappa; Sreejith Parameswaran; G Revathy
Journal:  Clin Exp Nephrol       Date:  2015-02-20       Impact factor: 2.801

Review 4.  Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders.

Authors:  Soham Rej; Dominique Elie; Istvan Mucsi; Karl J Looper; Marilyn Segal
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

5.  Renal Function and Hematology in Rats with Congenital Renal Hypoplasia.

Authors:  Hidenori Yasuda; Kohei Amakasu; Yuki Tochigi; Kentaro Katayama; Hiroetsu Suzuki
Journal:  Comp Med       Date:  2016-02       Impact factor: 0.982

6.  Association of impaired baroreflex sensitivity and increased arterial stiffness in peritoneal dialysis patients.

Authors:  Amit Gupta; Gaurav Jain; Manpreet Kaur; Ashok Kumar Jaryal; Kishore Kumar Deepak; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  Clin Exp Nephrol       Date:  2015-09-05       Impact factor: 2.801

Review 7.  Vitamin D and cardiovascular disease in chronic kidney disease.

Authors:  Gurpreet Kaur; Jatinder Singh; Juhi Kumar
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

8.  Prevalence and predictors of abdominal aortic calcification in healthy living kidney donors.

Authors:  D C T Leckstroem; T Bhuvanakrishna; A McGrath; D J A Goldsmith
Journal:  Int Urol Nephrol       Date:  2013-06-20       Impact factor: 2.370

Review 9.  Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.

Authors:  Tahir Kanji; Mandark Gandhi; Catherine M Clase; Robert Yang
Journal:  BMC Nephrol       Date:  2015-04-19       Impact factor: 2.388

10.  The prevalence of electrocardiographic early repolarization in an adult cohort with chronic kidney disease and its impact upon all-cause mortality and progression to dialysis.

Authors:  Reza Hajhosseiny; Ronak Rajani; Kaivan Khavandi; Frédéric A Sebag; Soudeh Mashayekhi; Matthew Wright; David Goldsmith
Journal:  Front Physiol       Date:  2013-05-31       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.